Harry H. Mansbach

Enzalutamide in Metastatic Prostate Cancer before Chemotherapy

Tomasz M. Beer, Andrew J. Armstrong, Dana E. Rathkopf et al. · New England Journal of Medicine · 2014 · 3K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Efficacy and safety of adjunctive ezogabine (retigabine) in refractory partial epilepsy

Martin J. Brodie, Holger Lerche, António Gil‐Nagel et al. · Neurology · 2010 · 191 citations

Medicine, Pharmacology, Pharmacotherapy +16

Effect of enzalutamide on health-related quality of life, pain, and skeletal-related events in asymptomatic and minimally symptomatic, chemotherapy-naive patients with metastatic castration-resistant prostate cancer (PREVAIL): results from a randomised, phase 3 trial

Yohann Loriot, Kurt Miller, Cora N. Sternberg et al. · The Lancet Oncology · 2015 · 191 citations

Medicine, Oncology, Pharmacology +17

Randomized, double-blind, placebo-controlled trial of ezogabine (retigabine) in partial epilepsy

Jacqueline A. French, Bassel Abou‐Khalil, Robert Leroy et al. · Neurology · 2011 · 186 citations

Medicine, Pharmacology, Pharmacotherapy +16

Initial clinical experience with IV tissue plasminogen activator for acute ischemic stroke: A multicenter survey

David Tanné, Vernice Bates, Piero Verro et al. · Neurology · 1999 · 182 citations

Medicine, Neurology, Cerebrovascular Neurosurgery +14